Advancing health equity in clinical trials by addressing the financial burden

The ability to effectively recruit and retain patients has a major impact on clinical trials timelines. And, for many patients, the financial burden from loss of income for missed work, the cost of transportation/travel for study-related appointments, childcare costs, etc. impacts their ability to join or remain in a trial.

At present, reimbursement and stipend programs are not widely and consistently implemented. Even when it is included, the amount often doesn’t adequately cover the costs incurred. This could be due to operational complexity, lack of awareness on the impact in health equity, and unknowns around tax and benefits impacts for patients.

This webinar brings together patient engagement and clinical development experts to discuss changing the industry paradigm by creating new industry standards that are fair, ethical, and meaningful to patients, simple for sites to implement, and with potential to expand into other countries. By standardizing and simplifying, we can positively influence adoption to improve patient recruitment, retention, and experience.

Topics covered include:
  • The impact of financial burden on patient participation
  • New ways to think about equitable patient compensation when planning studies
  • Creating a new industry framework for equitable compensation that can be scaled globally
watch now
Watch the webinar on demand
Rosamund Round

Rosamund Round

Vice President, Patient Engagement, Parexel International

Rosamund has spent more than 15 years devoted to simplifying the patient journey in clinical trials, with a focus on reducing geographical, financial, and practical barriers to study participation. Her first job in an oncology clinic at Massachusetts General Hospital sparked her passion for putting patients at the center of clinical trial planning and implementation.

Subsequent patient recruitment roles in both the pharma and CRO industries allowed her to explore better ways to communicate with patients. Rosamund’s current emphasis is on addressing literacy and health literacy, exploring technological advances, and generating new ideas to make clinical trial participation more accessible and convenient for patients.

Luke Gelinas

Luke Gelinas

Senior IRB Chair Director, Advarra

Luke Gelinas, PhD, is the Senior IRB Chair Director at Advarra, where he provides analysis and guidance on complex ethical issues arising in the course of clinical research study design and human participant protection. Previously, Luke led collaborative and multi-stakeholder projects addressing foundational and practical issues in research ethics including social media use, clinical trial priority-setting, and has explored the ethical and regulatory parameters paying research participants. His written work has appeared in leading medical and bioethics journals, and frequently lectures on various issues surrounding research ethics and human participant protection. Luke holds a PhD in Philosophy with a concentration in Ethics from the University of Toronto and an MA in Religion from Yale Divinity School.

Elizabeth Barksdale

Elizabeth Barksdale

Senior Director of Regulatory Affairs and Scientific Policy, LUNGevity Foundation

Elizabeth (Libby) Barksdale, PhD, is the Senior Director of Regulatory Affairs and Scientific Policy for LUNGevity Foundation. In her role she guides the development and execution of LUNGevity’s regulatory strategy as well as the organization’s Transforming Clinical Trials Initiative, a multi-stakeholder effort to streamline clinical trials and make them more patient-centric.

Previously, Libby served as the Assistant Director for Regulatory Science and Policy at the American Association for Cancer Research (AACR), where she led efforts aimed at increasing understanding of the regulatory ecosystem and enhancing the development of oncology products. Before joining the AACR, she was with the Federation of American Societies for Experimental Biology, where she focused on policies related to clinical research and biomedical research training.

Libby received her BS in Biology from Hope College and PhD in Molecular Medicine from The George Washington University. She sought out experiences in science policy while conducting postdoctoral research at the National Institute of Child Health and Human Development.

Kari Abitbol

Kari Abitbol

Director, Client Success, Endpoints News

As head of the client success team at Endpoints News, Kari oversees campaign delivery and strategy for all advertising and client-directed webinars. She brings nearly 20 years of diverse experience across strategic communications, content development and operational leadership.